DexCom
DXCM
$319.54
Share price
1.08%
Change (1 day)
-3.84%
Change (1 year)
Categories
Market capitalization of DexCom (DXCM)
Market cap: $31.35 Billion
As of May 2022 DexCom has a market cap of $31.35 Billion. This makes DexCom the world's 543th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of DexCom from 2005 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $32.84 B | -36.88% |
| 2021 | $52.04 B | 46.58% |
| 2020 | $35.50 B | 77.19% |
| 2019 | $20.03 B | 85.83% |
| 2018 | $10.78 B | 116.19% |
| 2017 | $4.98 B | -1.16% |
| 2016 | $5.04 B | -24.59% |
| 2015 | $6.69 B | 57.24% |
| 2014 | $4.25 B | 65.76% |
| 2013 | $2.56 B | 171.81% |
| 2012 | $0.94 B | 50.27% |
| 2011 | $0.62 B | -25.83% |
| 2010 | $0.84 B | 128.04% |
| 2009 | $0.37 B | 351.42% |
| 2008 | $0.08 B | -67.43% |
| 2007 | $0.25 B | 1.78% |
| 2006 | $0.24 B | -33.91% |
| 2005 | $0.37 B |
End of Day market cap according to different sources
On May 19th, 2022 the market cap of DexCom was reported to be:
$30.63 Billion
$31.01 Billion
$496.31 Billion
$31.01 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $460.04 B | 1,367.22% | 🇺🇸 USA |
 Abbott Laboratories ABT | $196.77 B | 527.56% | 🇺🇸 USA |
 Medtronic MDT | $136.52 B | 335.43% | 🇮🇪 Ireland |
 Becton Dickinson BDX | $71.93 B | 129.41% | 🇺🇸 USA |
 Edwards Lifesciences EW | $58.33 B | 86.06% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $4.60 B | -85.33% | 🇺🇸 USA |
 Quidel
QDEL | $4.15 B | -86.75% | 🇺🇸 USA |
 West Pharmaceutical WST | $22.20 B | -29.19% | 🇺🇸 USA |